🟢 Circio Holding is trading 8.26% up today after announcing a research collaboration with Full Circles Therapeutics

Circio Holding is trading at NOK 14.16 (+8.26%) after announcing a research collaboration with Full Circles Therapeutics on August 26.

• The collaboration combines circVec circular RNA technology with C4DNA vectors.
• The partners aim to develop a non-viral, re-dosable in-vivo cell-therapy platform, attracting investor interest in the company’s gene-therapy pipeline.
• The stock has extended its rally, rising from NOK 8.70 on August 17 to NOK 14.16; no trading-volume data was provided.